Tag: application

SAN DIEGO, June 12, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio^®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced the completion of its rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tinlarebant. Tinlarebant is an investigational, once-daily oral therapy for the treatment of Stargardt disease type 1 (STGD1), a rare, inherited retinal disease caused by mutations in the ABCA4 gene that leads to progressive and irreversible vision loss. STGD1 affects an estimated 53,000 people in the U.S. alone, and there are currently no approved treatment options for the disease.

NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) -- This announcement amends the effective date (or ex-date) previously circulated on June 08, 2026.

CINCINNATI, June 12, 2026 (GLOBE NEWSWIRE) -- The Jared Kamrass Scholarship for Public Service today announces its 2027 award cycle, inviting undergraduate students across the United States to apply for a one-time $1,000 scholarship. The initiative, created by political strategist and public service advocate Jared Kamrass, seeks to support young leaders who demonstrate a deep commitment to community impact and civic leadership.

ING reduces its stake in TMBThanachart Bank